PF-Atlas › Clinical Trials › NCT01851694

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

GLP-1 · Not specified

Registry ID
NCT01851694
Phase
Not specified
Status
Recruiting
Drug / intervention
GLP-1
Sponsor
University of Pennsylvania
Start
2013-05

About this trial

GLP-1 is evaluated in NCT01851694, a idiopathic pulmonary fibrosis study sponsored by University of Pennsylvania. Current status: Recruiting.

View NCT01851694 on ClinicalTrials.gov →

Explore related

GLP-1 Agonist Anti-Fibrotic Repurposing — Treatment profileAll GLP-1 trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT01851694 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.